Urinary matrix metalloproteinase-8 and -9 activities in type 2 diabetic subjects: A marker of incipient diabetic nephropathy?

Autor: Jeannette Boerop, Michaela Diamant, Cees Rustemeijer, Jan H. Verheijen, Roeland Hanemaaijer, Maarten E. Tushuizen, Henk J. G. Bilo, Nynke J. van der Zijl, Roger K. Schindhelm
Přispěvatelé: Internal medicine, Gastroenterology and hepatology, ICaR - Ischemia and repair
Rok vydání: 2010
Předmět:
Zdroj: Clinical Biochemistry
Clinical Biochemistry, 43(7-8), 635-639. Elsevier Inc.
Clinical Biochemistry, 43(7-8), 635-639. PERGAMON-ELSEVIER SCIENCE LTD
van der Zijl, N J, Hanemaaijer, L, Tushuizen, M E, Schindhelm, R K, Boerop, J, Rustemeijer, C, Bilo, H J, Verheijen, J H & Diamant, M 2010, ' Urinary matrix metalloproteinase-8 and-9 activities in type 2 diabetic subjects: A marker of incipient diabetic nephropathy? ', Clinical Biochemistry, vol. 43, no. 7-8, pp. 635-639 . https://doi.org/10.1016/j.clinbiochem.2010.02.006
ISSN: 0009-9120
DOI: 10.1016/j.clinbiochem.2010.02.006
Popis: Matrix metalloproteinases (MMPs) may play a pathophysiological role in the development of diabetic nephropathy (DN). We hypothesized that urinary MMP activity in patients with type 2 diabetes mellitus (T2DM) is related to a decline in renal function. We determined MMP-2, -8 and -9 activity in 24-h urine collections in relation to risk factors for ON in T2DM patients with (UA, n=27) and without albuminuria (NA, n=48) and controls (CO, n=28). MMP-8 and -9 levels were highest in UA patients (P
Databáze: OpenAIRE